Crossmark

Hormone Receptor Expression and QT interval at Baseline Correlate with Trastuzumab Associated Cardiotoxicity in HER2- Positive Breast Cancer Patients: A Prospective Study

Crossref DOI link: https://doi.org/10.1007/s12012-025-10059-7

Published Online: 2025-09-19

Published Print: 2025-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abo Samra, Dana https://orcid.org/0000-0003-1076-2634
Hanafi, Ibrahem https://orcid.org/0000-0001-5306-0128
Abo Samra, Dani

Naeem, Ahmad

Dayyoub, Assef
License Information

Text and Data Mining valid from 2025-09-19

Version of Record valid from 2025-09-19
More Information

Article History

Received: 18 December 2024

Accepted: 1 September 2025

First Online: 19 September 2025

Declarations

:

: The authors declare no competing interests.

: The study was approved by the institutional review board at the faculty of medicine of Damascus University.

Document is current

Any future updates will be listed below